Cargando…
Combined Efficacy of CXCL5, STC2, and CHI3L1 in the Diagnosis of Colorectal Cancer
OBJECTIVE: To improve the diagnostic capacity of serum biomarkers for colorectal cancer (CRC), we introduced three novel indicators, namely, the C-X-C motif chemokine ligand 5 (CXCL5), stanniocalcin 2 (STC2), and chitinase 3 like 1 (CHI3L1) and assessed their performances in the detection of CRC. ME...
Autores principales: | Li, Hui, Zhou, Xiaoping, Zhang, Haining, Jiang, Jifeng, Fu, Hu, Wang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142324/ https://www.ncbi.nlm.nih.gov/pubmed/35646113 http://dx.doi.org/10.1155/2022/7271514 |
Ejemplares similares
-
Effect of STC2 gene silencing on colorectal cancer cells
por: Li, Qianyuan, et al.
Publicado: (2019) -
Upregulation of STC2 in colorectal cancer and its clinicopathological significance
por: Zhang, Chunxiao, et al.
Publicado: (2019) -
CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023) -
A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block “eat-me” signal
por: Luo, Min, et al.
Publicado: (2023) -
Research progress of STC2 in breast cancer
por: Niu, Xuezhi, et al.
Publicado: (2021)